Star Cement Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 5:54 pm

Quick Insight

Star Cement Ltd's current share price of ₹263 seems overvalued with a P/E ratio of 62.9, indicating high investor expectations. Despite a respectable ROE of 6.04% and ROCE of 8.38%, the company's operational efficiency, as reflected in the OPM of 25%, appears healthy. The company's capital structure is moderately leveraged with borrowings of ₹403Cr and a comfortable interest coverage ratio of 18.63x. The diversified shareholding pattern with significant promoter holding at 57.69% provides stability. However, the high P/BV ratio of 3.02x suggests the stock may be trading at a premium. Investors should closely monitor operational performance and valuation metrics for potential investment opportunities in the future.

Competitors of Star Cement Ltd

All Competitor Stocks of Star Cement Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:41 am

Below is a detailed analysis of the quarterly data for Star Cement Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,052.00 Cr.. The value appears strong and on an upward trend. It has increased from 719.00 Cr. (Dec 2024) to 1,052.00 Cr., marking an increase of 333.00 Cr..
• For Expenses, as of Mar 2025, the value is 789.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 615.00 Cr. (Dec 2024) to 789.00 Cr., marking an increase of 174.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 263.00 Cr.. The value appears strong and on an upward trend. It has increased from 104.00 Cr. (Dec 2024) to 263.00 Cr., marking an increase of 159.00 Cr..
• For OPM %, as of Mar 2025, the value is 25.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Dec 2024) to 25.00%, marking an increase of 11.00%.
• For Other Income, as of Mar 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Dec 2024) to 5.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Mar 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Dec 2024) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 88.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 89.00 Cr. (Dec 2024) to 88.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 171.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Dec 2024) to 171.00 Cr., marking an increase of 163.00 Cr..
• For Tax %, as of Mar 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from -19.00% (Dec 2024) to 28.00%, marking an increase of 47.00%.
• For Net Profit, as of Mar 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Dec 2024) to 123.00 Cr., marking an increase of 114.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.05. The value appears strong and on an upward trend. It has increased from 0.22 (Dec 2024) to 3.05, marking an increase of 2.83.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:57 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:18 am

Below is a detailed analysis of the balance sheet data for Star Cement Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 40.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,839.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,670.00 Cr. (Mar 2024) to 2,839.00 Cr., marking an increase of 169.00 Cr..
• For Borrowings, as of Mar 2025, the value is 403.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 147.00 Cr. (Mar 2024) to 403.00 Cr., marking an increase of 256.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 825.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 745.00 Cr. (Mar 2024) to 825.00 Cr., marking an increase of 80.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,107.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,602.00 Cr. (Mar 2024) to 4,107.00 Cr., marking an increase of 505.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,421.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,416.00 Cr. (Mar 2024) to 2,421.00 Cr., marking an increase of 1,005.00 Cr..
• For CWIP, as of Mar 2025, the value is 220.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,022.00 Cr. (Mar 2024) to 220.00 Cr., marking a decrease of 802.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,464.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,163.00 Cr. (Mar 2024) to 1,464.00 Cr., marking an increase of 301.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,107.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,602.00 Cr. (Mar 2024) to 4,107.00 Cr., marking an increase of 505.00 Cr..

Notably, the Reserves (2,839.00 Cr.) exceed the Borrowings (403.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Star Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 5. It has decreased from 7.30 (Mar 24) to 4.18, marking a decrease of 3.12.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 5. It has decreased from 7.30 (Mar 24) to 4.18, marking a decrease of 3.12.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.39. This value is within the healthy range. It has increased from 10.93 (Mar 24) to 12.39, marking an increase of 1.46.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.24. It has increased from 67.05 (Mar 24) to 71.24, marking an increase of 4.19.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.24. It has increased from 67.05 (Mar 24) to 71.24, marking an increase of 4.19.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 78.27. It has increased from 72.01 (Mar 24) to 78.27, marking an increase of 6.26.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.58. This value is within the healthy range. It has increased from 14.42 (Mar 24) to 14.58, marking an increase of 0.16.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.37. This value is within the healthy range. It has decreased from 10.79 (Mar 24) to 6.37, marking a decrease of 4.42.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.58. This value is within the healthy range. It has decreased from 10.48 (Mar 24) to 5.58, marking a decrease of 4.90.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.18. This value is within the healthy range. It has decreased from 7.30 (Mar 24) to 4.18, marking a decrease of 3.12.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.18. This value is within the healthy range. It has decreased from 7.30 (Mar 24) to 4.18, marking a decrease of 3.12.
• For PBDIT Margin (%), as of Mar 25, the value is 18.62. This value is within the healthy range. It has decreased from 20.02 (Mar 24) to 18.62, marking a decrease of 1.40.
• For PBIT Margin (%), as of Mar 25, the value is 8.13. This value is below the healthy minimum of 10. It has decreased from 14.98 (Mar 24) to 8.13, marking a decrease of 6.85.
• For PBT Margin (%), as of Mar 25, the value is 7.13. This value is below the healthy minimum of 10. It has decreased from 14.55 (Mar 24) to 7.13, marking a decrease of 7.42.
• For Net Profit Margin (%), as of Mar 25, the value is 5.33. This value is within the healthy range. It has decreased from 10.13 (Mar 24) to 5.33, marking a decrease of 4.80.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.34. This value is below the healthy minimum of 8. It has decreased from 10.13 (Mar 24) to 5.34, marking a decrease of 4.79.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.86. This value is below the healthy minimum of 15. It has decreased from 10.88 (Mar 24) to 5.86, marking a decrease of 5.02.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.01. This value is below the healthy minimum of 10. It has decreased from 15.46 (Mar 24) to 8.01, marking a decrease of 7.45.
• For Return On Assets (%), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 8.19 (Mar 24) to 4.11, marking a decrease of 4.08.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.10, marking an increase of 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.13. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.13, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.82. It has decreased from 0.86 (Mar 24) to 0.82, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 1.5. It has increased from 0.98 (Mar 24) to 1.15, marking an increase of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.65, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 4. It has increased from 1.31 (Mar 24) to 1.45, marking an increase of 0.14.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 18.63. This value is within the healthy range. It has decreased from 46.25 (Mar 24) to 18.63, marking a decrease of 27.62.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.34. This value is within the healthy range. It has decreased from 24.42 (Mar 24) to 6.34, marking a decrease of 18.08.
• For Enterprise Value (Cr.), as of Mar 25, the value is 9,027.28. It has decreased from 9,177.06 (Mar 24) to 9,027.28, marking a decrease of 149.78.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has decreased from 3.15 (Mar 24) to 2.85, marking a decrease of 0.30.
• For EV / EBITDA (X), as of Mar 25, the value is 15.32. This value exceeds the healthy maximum of 15. It has decreased from 15.75 (Mar 24) to 15.32, marking a decrease of 0.43.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 3.14 (Mar 24) to 2.75, marking a decrease of 0.39.
• For Price / BV (X), as of Mar 25, the value is 3.02. This value exceeds the healthy maximum of 3. It has decreased from 3.37 (Mar 24) to 3.02, marking a decrease of 0.35.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 3.14 (Mar 24) to 2.75, marking a decrease of 0.39.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness